Pharma & Biotech VC & Investment News
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Today's issue
Refine Search
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
Shanghai-based Leading Tac Pharmaceutical has announced the successful completion of a series A financing round, raising over 100 million yuan ($14 million). 21 November 2024
Biotechnology
A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry promised to build bold, science-driven therapeutics companies. 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Californian oncology-focused biotech Avenzo Therapeutics has announced a pair of important updates. 19 November 2024
Pharmaceutical
In yet another sign of the mounting interest in radiopharmaceuticals, Tongrui Biopharma, a Chinese innovator in this area, has announced the completion of a $100 million series A+ financing round. 18 November 2024
Biotechnology
Shanghai-based biopharma Zai Lab has announced the pricing of its underwritten public offering at $25.50 per share, aiming to raise around $200 million. 15 November 2024
Pharmaceutical
New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series B financing to further advance its portfolio of clinical-stage, nutrient-stimulated hormone (NuSH) analog peptides. 14 November 2024
Pharmaceutical
Life science investor Syncona has announced the launch of its newest portfolio company, Slingshot Therapeutics, through the Syncona Accelerator initiative. 14 November 2024
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Biotechnology
Trace Neuroscience, a newly launched biopharma based in San Francisco, aims to advance treatments for neurodegenerative diseases, starting with amyotrophic lateral sclerosis (ALS). 12 November 2024
Biotechnology
Geron Corporation, a biopharma company focused on telomerase inhibition therapies, has announced a $375 million financing agreement aimed at supporting the commercial rollout of Rytelo (imetelstat). 11 November 2024
Biotechnology
An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug R&D. 11 November 2024
Biotechnology
US biotech venture fund Aditum Bio and China’s Leads Biolabs today announced the formation of Oblenio Bio, marking the thirteenth company launched by Aditum. 7 November 2024
Biotechnology
US biotherapeutics company Gelesis is to go public via a merger with Capstar Special Purpose Acquisition, a special purpose acquisition company. 20 July 2021
Biotechnology
US biotech Amylyx Pharmaceuticals has announced the closing of an oversubscribed $135 million Series C financing. 20 July 2021
Biotechnology
California-based Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise undruggable disease-causing targets, has announced the closing of an $88.5 million Series B financing round. 19 July 2021
Pharmaceutical
The European Investment Bank (EIB) and Laboratoires Théa have signed a 50 million-euro ($59 million) finance contract. 15 July 2021
Biotechnology
Cambridge, USA-based biotech Ribon Therapeutics has closed a $65 million financing, which the company says will be used to support the clinical development of its novel precision medicine candidates. 14 July 2021
Biotechnology
Cambridge, Massachusetts-based Prime Medicine, a company delivering on the promise of Prime Editing to provide lifelong cures to patients, has announced its launch with $315 million in financing. 14 July 2021
Biotechnology
The UK’s BioIndustry Association (BIA) and Clarivate today released new data, showing that the Britain’s biotech and life sciences sector is on the cusp of a golden age driven by strong demand from global investors for UK innovation, with £1.56 billion invested in the last quarter (March 2021 – May 2021). 5 July 2021
Biotechnology
Third Rock Ventures has announced the launch of Abata Therapeutics, a company focused on translating the biology of regulatory T cells (Tregs) into transformational medicines for patients living with progressive multiple sclerosis (MS) and other severe autoimmune and inflammatory diseases. 24 June 2021
Biotechnology
Funds managed by Blackstone have committed $250 million towards the launch of a new autologous and allogeneic universal chimeric antigen receptor (CAR) T-cell therapy company. 23 June 2021
Pharmaceutical
As in other industries, the rise of the special purpose acquisition company (SPAC) as a means to going public is becoming more evident in pharma and biotech. 23 June 2021
Biotechnology
Biotech funder and incubator Flagship Pioneering has raised an additional $2.2 billion, augmenting the capital base for its Fund VII, which was reopened in April. 15 June 2021
Biotechnology
Independent private equity firm Jeito Capital, which is dedicated to biotech and biopharma, today announced that it has become a key investor as part of a $67 million Series B financing round in Alentis Therapeutics. 15 June 2021
Biotechnology
Valo Health has announced its intention to list as a publicly-traded company, with a significant investment from backers including Khosla Ventures, Koch Disruptive Technologies and Flagship Pioneering. 10 June 2021
Biotechnology
Consulting firm McKinsey has provided a report presenting Europe as an attractive place to be in biotech. 9 June 2021
Biotechnology
The launch of Alcyone Therapeutics, a biotech focused on developing gene therapies for central nervous system (CNS) disorders, has been announced. 9 June 2021
Biotechnology
US immuno-dermatology specialist biotech Dermavant Sciences, a subsidiary of Roivant Sciences, has entered into a $160 million revenue interest purchase and sale agreement for its investigational product tapinarof with three participants that include Marathon Asset Management, NovaQuest Capital Management and a third institutional investor located in Boston. 7 June 2021
Biotechnology
UK antibody drug conjugate (ADC) company Iksuda Therapeutics (Iksuda) today announced it has completed a $47 million (~£34 million) financing round, co-led by Mirae Asset Capital and its subsidiaries, Celltrion and Premier Partners 7 June 2021
Pharmaceutical
USA-headquartered digital medicines company Akili Interactive, maker of EndeavorRx, the first and only prescription video game treatment, today announced $160 million in combined equity and debt financing. 26 May 2021
Biotechnology
Ysios Capital, Spain’s largest and leading European venture capital firm specialized in the biotechnology sector, announces today that it has closed its third fund, Ysios BioFund 3 (YBF 3) at 216 million euros ($260 million). 26 May 2021
Biotechnology
Swiss clinical-stage biotech Numab Therapeutics today announced the closing of a 100 million Swiss franc (~$110 million) Series C financing. 20 May 2021
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze